Global Life Science Ventures — Investing in the life sciences

Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than € 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.

Text size

Rainer J. Hoegg

Rainer J. Hoegg, MBA, Dipl. Biol., Group Controller/ Analyst

Mr. Hoegg has three years experience in the biotech industry and finance. With a diploma both in science and business administration, his background includes hands-on experience as an assistant to the CEO of a former biotech start-up. He joined GLSV in 2004 and his duties include the monitoring of the performance of portfolio companies, the preparation of quarterly reports to investors, as well as internal controlling and administration. He is also involved in the monitoring of public shareholdings and provides analyst support to the investment team.

Born in 1973, Mr Hoegg obtained a German MSc in biology from the University of Constance in 2000. Aiming at a career in the growing biotechnology sector, he subsequently studied business administration with a focus on finance and accounting at the Technical University of Munich and at Virginia Polytechnic Institute and State University. His MBA thesis covered the valuation of biotechnology ventures and included the analysis and valuation of an established private biotech company from the Munich area.

< back